[T细胞在B细胞淋巴瘤中招募免疫疗法 - 所有治疗线路的未来骨干?]
Deutsche medizinische Wochenschrift (1946)
|May 15, 2024
概括
新的免疫疗法,如CD19 CAR-T细胞和双特异性抗体,为B细胞淋巴瘤患者提供了更好的生存率. 这些治疗方法显示出高疗效和可控的副作用,代表了淋巴瘤治疗的重大进展.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 血液学 血液学 血液学
背景情况:
- B细胞淋巴瘤,特别是激进型淋巴瘤,在治疗方面取得了显著的进步.
- CD19 CAR-T细胞疗法 (Axi-cel,Liso-cel) 已被批准用于二线DLBCL治疗,比传统方法改善无进展生存率.
- 双特异性T细胞参与抗体为复发性疾病提供了新的选择,即使在CAR-T治疗后.
研究的目的:
- 审查B细胞淋巴瘤免疫学向治疗的进展.
- 为了比较CD19 CAR-T细胞和双特异性抗体的疗效和安全性.
- 讨论这些新型免疫疗法的潜在未来应用.
主要方法:
- 审查当前的临床数据和B细胞淋巴瘤的批准疗法.
- 与标准治疗相比,CAR-T细胞的无进展生存率和耐受性的比较.
- 对复发性淋巴瘤中双特异性抗体的疗效和副作用概况的分析.
主要成果:
- CD19 CAR-T细胞 (Axi-cel,Liso-cel) 在二线DLBCL中表现出更好的无进展生存率.
- 双特异性抗体在复发性淋巴瘤中显示出有效性,包括后CAR-T设置.
- 卡特-T疗法具有可接受的耐受性,特别是在老年患者或并发症患者中.
- 与CAR-T细胞相比,双特异性抗体具有有利的毒性概况,ICANS频率较低.
结论:
- CD19 CAR-T细胞和双特异性抗体代表了B细胞淋巴瘤治疗的重大进展.
- 这些免疫疗法具有显著的疗效,可管理的副作用概况.
- 双特异性抗体是一种有希望的,高效的免疫疗法用于淋巴瘤,具有有利的毒性概况.
相关概念视频
Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
Cancer Vaccines
358
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
358
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cells of the Adaptive Immune Response
980
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
980
Special Features of Adaptive Immunity
804
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
804


